Findings

What do systematic reviews say?

2,973 questions · 3,072 findings · 410 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 559 · 18.2%GRADE not reported 143 · 4.7%Very low 654 · 21.3%Low 833 · 27.1%Moderate 683 · 22.2%High 200 · 6.5%

Intervention not reported

Duration of iNO therapy (days) · Neonates with PPHN

1 finding from 1 review

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants 2016 · Cochrane Headline outcomes only
no estimate extracted
21 participants
Low

Intervention not reported

Total duration of mechanical ventilation (days) · Neonates with PPHN

1 finding from 1 review

Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants 2016 · Cochrane Headline outcomes only
no estimate extracted
21 participants
Low

Summary of findings: Behavioural treatments vs usual care or no treatment

Prolonged abstinence at longest · smokers with COPD

Behavioural treatment probably leads to higher prolonged abstinence at longest compared with no treatment or usual care (moderate certainty).

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 25.38 [8.03, 80.22]
1 study · 3562 participants
Moderate

Pharmacological treatment vs a different pharmacological treatment

Prolonged abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 166 participants
GRADE not reported

Pharmacological treatment vs a different pharmacological treatment

Point prevalence abstinence at longest · smokers with COPD

Pharmacological treatment probably leads to higher point prevalence abstinence at longest compared with a different pharmacological treatment (moderate certainty).

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 2.5 [1.47, 4.26]
1 study · 543 participants
Moderate

Combination of interventions vs different (combination) interventions or usual care

Prolonged abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 6431 participants
GRADE not reported

Combination of interventions vs different (combination) interventions or usual care

Point prevalence abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1535 participants
GRADE not reported

Summary of findings: Behavioural treatments vs usual care or no treatment

Point prevalence abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 3618 participants
GRADE not reported

One form of behavioural treatment vs a different form of behavioural treatment

Prolonged abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 739 participants
GRADE not reported

One form of behavioural treatment vs a different form of behavioural treatment

Point prevalence abstinence at longest · smokers with COPD

1 finding from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 500 participants
GRADE not reported

Pharmacological treatment vs placebo

Prolonged abstinence at longest · smokers with COPD

Pharmacological treatment leads to higher prolonged abstinence at longest compared with placebo (high certainty).

5 findings from 1 review

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 2.53 [1.83, 3.5]
4 studies · 1429 participants
High
Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 2.6 [1.29, 5.24]
1 study · 370 participants
High
Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 2.03 [1.26, 3.28]
2 studies · 503 participants
Moderate

Show 2 more findings

Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 3.34 [1.88, 5.92]
1 study · 504 participants
High
Smoking cessation for people with chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
RR 2.54 [0.87, 7.44]
1 study · 100 participants
Low

Intervention not reported

Improvement in measures of health behavior at 24 to 48 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 29474 participants
Very low

Intervention not reported

Improvement in measures of health status at 24 to 60 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 14431 participants
Very low

Intervention not reported

Improvement in measures of health status at 6 to 36 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 21607 participants
Low

Intervention not reported

Improvement in measures of health behavior at 3 to 48 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 4957 participants
Very low

Intervention not reported

Improvement in measures of health status at 12 to 48 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1833 participants
Low

Intervention not reported

Improvement in measures of health behavior at 4 to 36 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 4447 participants
Low

Intervention not reported

Improvement in measures of health status at 2 to 12 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 251 participants
Low

Intervention not reported

Improvement in measures of health behavior at 6 to 36 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1209 participants
Very low

Intervention not reported

Improvement in measures of health status at 12 to 40 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 783 participants
Low